ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
244.99
-1.23 (-0.50%)
Nov 19, 2025, 4:00 PM EST - Market closed
ResMed Employees
ResMed had 9,980 employees as of June 30, 2024. The number of employees decreased by 160 or -1.58% compared to the previous year.
Employees
9,980
Change (1Y)
-160
Growth (1Y)
-1.58%
Revenue / Employee
$526,794
Profits / Employee
$144,079
Market Cap
35.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | 7,770 | 530 | 7.32% |
| Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
| Jun 30, 2018 | 5,940 | -140 | -2.30% |
| Jun 30, 2017 | 6,080 | 830 | 15.81% |
| Jun 30, 2016 | 5,250 | 910 | 20.97% |
| Jun 30, 2015 | 4,340 | 240 | 5.85% |
| Jun 30, 2014 | 4,100 | 200 | 5.13% |
| Jun 30, 2013 | 3,900 | 200 | 5.41% |
| Jun 30, 2012 | 3,700 | 250 | 7.25% |
| Jun 30, 2011 | 3,450 | 250 | 7.81% |
| Jun 30, 2010 | 3,200 | 300 | 10.34% |
| Jun 30, 2009 | 2,900 | 200 | 7.41% |
| Jun 30, 2008 | 2,700 | 0 | - |
| Jun 30, 2007 | 2,700 | 200 | 8.00% |
| Jun 30, 2006 | 2,500 | 573 | 29.74% |
| Jun 30, 2005 | 1,927 | 407 | 26.78% |
| Jun 30, 2004 | 1,520 | 56 | 3.83% |
| Jun 30, 2003 | 1,464 | 214 | 17.12% |
| Jun 30, 2002 | 1,250 | 297 | 31.16% |
| Jun 30, 2001 | 953 | 348 | 57.52% |
| Jun 30, 2000 | 605 | 104 | 20.76% |
| Jun 30, 1999 | 501 | 111 | 28.46% |
| Jun 30, 1998 | 390 | 106 | 37.32% |
| Jun 30, 1997 | 284 | 55 | 24.02% |
| Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RMD News
- 2 days ago - ResMed: Safe Bet For A Recession Environment - Seeking Alpha
- 19 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 20 days ago - ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026 - GlobeNewsWire
- 5 weeks ago - Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 - GlobeNewsWire
- 6 weeks ago - Top 50 High-Quality Dividend Growth Stocks For October 2025 - Seeking Alpha
- 2 months ago - ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025 - GlobeNewsWire